Daniel Bengtsson

Affilierad forskare

Presentation

Publications

2022

Daniel Bengtsson, Oskar Ragnarsson, Katarina Berinder, Per Dahlqvist, Britt Edén Engström, Bertil Ekman, Charlotte Höybye, Jacob Järås, Stig Valdemarsson, Pia Burman, Jeanette Wahlberg (2022) Increased Mortality Persists after Treatment of Cushing's Disease: A Matched Nationwide Cohort Study Journal of the Endocrine Society, Vol. 6 (Article in journal) Continue to DOI

2021

Olivera Casar-Borota, Henning Bünsow Boldt, Britt Edén Engström, Marianne Skovsager Andersen, Bertrand Baussart, Daniel Bengtsson, Katarina Berinder, Bertil Ekman, Ulla Feldt-Rasmussen, Charlotte Höybye, Jens Otto L. Jörgensen, Anders Jensen Kolnes, Marta Korbonits, Åse Krogh Rasmussen, John R. Lindsay, Paul Benjamin Loughrey, Dominique Maiter, Emilija Manojlovic-Gacic, Jens Pahnke, Pietro Luigi Poliani, Vera Popovic, Oskar Ragnarsson, Camilla Schalin-Jantti, David Scheie, Miklos Toth, Chiara Villa, Martin Wirenfeldt, Jacek Kunicki, Pia Burman (2021) Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations Journal of Clinical Endocrinology and Metabolism, Vol. 106, p. 1183-1194 (Article in journal) Continue to DOI
Daniel Bengtsson (2021) Cushing's disease and aggressive pituitary tumours: Aspects on epidemiology, treatment, and long-term follow-up
Daniel Bengtsson, Oskar Ragnarsson, Katarina Berinder, Per Dahlqvist, Britt Edén Engström, Bertil Ekman, Charlotte Höybye, Pia Burman, Jeanette Wahlberg (2021) Psychotropic drugs in patients with Cushing's disease before diagnosis and at long-term follow-up - a nationwide study. Journal of Clinical Endocrinology and Metabolism, Article dgab079 (Article in journal) Continue to DOI

2018

Daniel Bengtsson, H. D. Schroder, K. Berinder, D. Maiter, C. Hoybye, O. Ragnarsson, U. Feldt-Rasmussen, A. Krogh Rasmussen, A. van der Lely, M. Petersson, G. Johannsson, M. Andersen, P. Burman (2018) Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide Endocrine, Vol. 62, p. 737-739 (Article in journal) Continue to DOI